3118 Stock Overview
Engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Level Biotechnology Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$31.90 |
| 52 Week High | NT$39.90 |
| 52 Week Low | NT$29.60 |
| Beta | 0.56 |
| 11 Month Change | -3.33% |
| 3 Month Change | 2.24% |
| 1 Year Change | 6.33% |
| 33 Year Change | 7.23% |
| 5 Year Change | 19.03% |
| Change since IPO | 145.20% |
Recent News & Updates
Recent updates
Some Investors May Be Worried About Level Biotechnology's (GTSM:3118) Returns On Capital
Apr 27
Calculating The Fair Value Of Level Biotechnology Inc. (GTSM:3118)
Mar 16Here's What You Should Know About Level Biotechnology Inc.'s (GTSM:3118) 3.6% Dividend Yield
Feb 14Does Level Biotechnology's (GTSM:3118) Returns On Capital Reflect Well On The Business?
Jan 24
Level Biotechnology Inc.'s (GTSM:3118) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Jan 03Calculating The Intrinsic Value Of Level Biotechnology Inc. (GTSM:3118)
Dec 16Here's Why We Think Level Biotechnology's (GTSM:3118) Statutory Earnings Might Be Conservative
Nov 28Shareholder Returns
| 3118 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | -0.6% | -1.8% | -2.4% |
| 1Y | 6.3% | -8.2% | 36.2% |
Return vs Industry: 3118 exceeded the TW Healthcare industry which returned -8.2% over the past year.
Return vs Market: 3118 underperformed the TW Market which returned 36.2% over the past year.
Price Volatility
| 3118 volatility | |
|---|---|
| 3118 Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in TW Market | 8.8% |
| 10% least volatile stocks in TW Market | 2.9% |
Stable Share Price: 3118 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 3118's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 126 | n/a | www.level.com.tw |
Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. It also markets and distributes biomedical precision equipment. In addition, the company provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production.
Level Biotechnology Inc. Fundamentals Summary
| 3118 fundamental statistics | |
|---|---|
| Market cap | NT$1.04b |
| Earnings (TTM) | NT$61.91m |
| Revenue (TTM) | NT$697.15m |
16.7x
P/E Ratio1.5x
P/S RatioIs 3118 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3118 income statement (TTM) | |
|---|---|
| Revenue | NT$697.15m |
| Cost of Revenue | NT$468.73m |
| Gross Profit | NT$228.42m |
| Other Expenses | NT$166.51m |
| Earnings | NT$61.91m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 1.91 |
| Gross Margin | 32.76% |
| Net Profit Margin | 8.88% |
| Debt/Equity Ratio | 0% |
How did 3118 perform over the long term?
See historical performance and comparison